Completed
Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks
NCT01756157
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- ViroPharma Investigational Site Birmingham, Alabama, United States
- ViroPharma Investigational Site Scottsdale, Arizona, United States
- ViroPharma Investigational Site Bentonville, Arkansas, United States
- ViroPharma Investigational Site Walnut Creek, California, United States